期刊文献+

妊娠期高血压疾病孕妇尿液中激肽原1含量的变化 被引量:2

Change of urinary kininogen-1 content in pregnant women with hypertensive disorder complicating pregnancy
原文传递
导出
摘要 目的:探讨尿液中激肽原1(KNG1)在评估妊娠期高血压疾病严重程度中的临床意义。方法:选取妊娠期高血压、轻度子痫前期、重度子痫前期孕妇及正常健康足月妊娠女性各20例,分别检测其尿液中的KNG1浓度,并与平均动脉压和24 h尿蛋白进行相关性分析。结果:轻度子痫前期组孕妇尿液中KNG1浓度和正常妊娠组比较,差异无统计学意义(P>0.05);而妊娠期高血压组和重度子痫前期组孕妇尿液中KNG1浓度相对于正常妊娠组显著下降,差异有统计学意义(P<0.05),且重度子痫前期组孕妇尿液中KNG1浓度显著低于轻度子痫前期组(P<0.05)。Pearson相关分析显示:尿液中KNG1浓度与平均动脉压呈显著负相关(r=-0.351,P=0.001),但与24 h尿蛋白无相关性(r=-0.136,P=0.301)。结论:尿液中KNG1含量可以作为一项灵敏和可靠指标来评估妊娠期高血压疾病的病情,且在一定程度上反映疾病的严重程度。 Objective: To explore the clinical significance of urinary kininogen- 1 ( KNG1 ) in evaluating the severity of hyperten- sive disorder complicating pregnancy (HDCP) . Methods: Twenty pregnant women with HDCP, twenty pregnant women with mild pre- eclampsia, twenty pregnant women with severe preeclampsia, and twenty healthy full-term pregnant women were selected, KNG1 concentra- tions were detected respectively, then the correlation with mean arterial pressure and 24-hour urinary protein was analyzed. Results: There was no statistically significant difference in urinary KNG1 concentration between mild preeclampsia group and normal pregnancy group (P〉 0. 05) ; urinary KNG1 concentrations in HDCP group and severe preeclampsia group were statistically significantly lower than that in normal pregnancy group ( P〈0. 05 ), urinary KNG1 concentration in severe preeclampsia group was statistically significantly lower than that in mild preeclampsia group (P〈0.05) . Pearson correlation analysis showed that urinary KNG1 concentration was significantly negatively correlated with mean arterial pressure ( r= -0. 351, P=0. 001 ), but there was no correlation between urinary KNG1 concentration and 24-hour urinary protein (r=-0. 136, P=0. 301 ) . Conclusion: Urinary KNG1 content can be used as a sensitive and reliable index to evaluate HDCP, and it can reflect severity of the disease to a certain degree.
出处 《中国妇幼保健》 CAS 2015年第15期2339-2341,共3页 Maternal and Child Health Care of China
基金 深圳市卫生计生系统科研项目〔201402067〕
关键词 尿液 激肽原1 妊娠期高血压疾病 Urine Kininogen-1 Hypertensive disorder complicating pregnancy
  • 相关文献

参考文献11

  • 1胡金艳,郭红霞,胡水旺,王晨虹.妊娠期高血压疾病与正常孕妇尿液蛋白质组分析[J].实用妇产科杂志,2013,29(6):446-450. 被引量:14
  • 2Tu L, Xu X, Wan H, et al. Delivery of recombinant adeno- associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats [ J 1. Hum Gene Ther, 2008, 19 (4): 318-330.
  • 3Rapala- Kozik M, Karkowska J, Jacker A, et al. Kininogen binding to the surfaces of macrophages [ J]. Int Immunop- harmacol, 2008, 8 (2): 211-216.
  • 4Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins [ J]. Biol Chem, 2006, 387 (6) : 643-652.
  • 5Yousef GM, Diamandis EP. The new human tissue kallikrein gene family : structure, function, and association to disease [J]. EndocrRev, 2001, 22 (2): 184-204.
  • 6Valds G, Germain AM, Corthom J, et al. Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation [ J]. Endocrine, 2001, 16 ( 3 ) : 207-215.
  • 7Mahaneem M, Ernest TL, Harhindar J, et al. Tissue kallikrein and kininogen levels in fetoplacental tissues from normotensive pregnant women and women with pregnancy- induced hyperten- sion [ J]. Eur J Obstet Gynecol Reprod Biol, 2007, 134 (1): 15-19.
  • 8Valds G, Chacn C, Corthom J, et al. Tissue kallikrein in hu- man placenta in early and late gestation [ J ]. Endocrine, 2001, 14 (2): 197-204.
  • 9陈静,沈理,滕银成.组织激肽释放酶、激肽原在子痫前期患者胎盘中表达的研究[J].现代妇产科进展,2008,17(9):676-679. 被引量:3
  • 10孙秀荣,苏放明.激肽释放酶基因在子痫前期患者中的表达及活性变化[J].现代妇产科进展,2007,16(9):667-669. 被引量:2

二级参考文献28

  • 1戴勇,彭武建,李体远,杜珙,徐卓佳.导入人组织激肽释放酶基因治疗肾血管性高血压实验研究[J].中国分子心脏病学杂志,2005,5(2):452-456. 被引量:8
  • 2Erdos EG. Kinins, the long march-a personal view [ J ]. Cardiovasc Res ,2002,54:485-491
  • 3Imamura,Potempa J,Travis J. Activation of the kallikreinkinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases [ J ]. Biol Chem,2004,385:989-996
  • 4Agostoni A, Cugno M. The kinin system: biological mechanisms and clinical implications [ J ]. Recenti Ping Med, 2001,92:764-773
  • 5Valdes G, Chacon C, Corthom J, et al. Tissue kallikrein in human placenta in early and late gestation [ J ]. Endocrine,2001,14 : 197-204
  • 6Agustin C,Jose V, Marshall L. World Health Organization Systematic Review of Screening Tests for Pre-eclampsia [ J ]. Obstet Gynecol,2004,104 : 1367-1391
  • 7Magistroni R, Ligabue G, Lupo V, et al. Proteomic analysis of urine from protein uricpatients shows a proteolitic activity directed against albumin [ J ]. Nephrology Dialysis Transplantation, 2009, 24 ( 5 ) : 1672 - 1681.
  • 8Syed G Musharraf, Naghma Hashmi, Iqbal Choudhary M, et al. Com- parison of plasma from healthy nonsmokers ,smokers, and lung cancer patients : pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI- TOF-MS [ J ]. Biomarkers ,2012,17 ( 3 ) :223 - 230.
  • 9Laszlo Mark, Gergely Gulyas-Fekete, Antonia Marcsik, et al. Analysis of ancient mycolic acids by using MALDI-TOF-MS [J].Journal of Ar- chaeological Science ,2011,38 ( 5 ) : 1111 - 1118.
  • 10Uta JE, Thiell, Ralph Fehensl, et al. Analysis of differentially ex- pressed proteins in oral squamous cell carcinoma by MALDI-TOF-MS [J]. J Oral Pathol Med,2011,40(5) :369 -379.

共引文献16

同被引文献9

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部